Sept. 8, 2023, 5:45 p.m. | Globe Newswire

AI – AI-TechPark ai-techpark.com

Otsuka Pharmaceutical Co., Ltd. (Otsuka) and ShapeTX, the programmable medicine company using AI and RNA to end genetic diseases, today announce a multi-target collaboration to develop intravitreally-delivered adeno-associated viruses (AAVs) for ocular diseases, with options to add additional targets and tissue types. The companies will collaborate to apply ShapeTX’s AAVid™ capsid...


The post Otsuka collaborates with ShapeTX first appeared on AI-TechPark.

ai apply collaboration companies diseases medicine pharmaceutical rna targets types viruses

Senior Machine Learning Engineer

@ GPTZero | Toronto, Canada

ML/AI Engineer / NLP Expert - Custom LLM Development (x/f/m)

@ HelloBetter | Remote

Doctoral Researcher (m/f/div) in Automated Processing of Bioimages

@ Leibniz Institute for Natural Product Research and Infection Biology (Leibniz-HKI) | Jena

Seeking Developers and Engineers for AI T-Shirt Generator Project

@ Chevon Hicks | Remote

Principal Data Architect - Azure & Big Data

@ MGM Resorts International | Home Office - US, NV

GN SONG MT Market Research Data Analyst 11

@ Accenture | Bengaluru, BDC7A